Sorry, looks like we don't have enough of this product.
The honest UK buyer's guide to magnesium glycinate. We audited 8 major UK brands against 7 criteria — including the elemental dose most labels obscure, the chelation yield 23 of 28 products fail, and the 2025 Nature and Science of Sleep RCT that no UK supplement brand currently cites. The Elysium 7-Point Audit, full brand scorecards, and the dosing framework anchored to the NHS reference intake.
We audited every major UK magnesium glycinate against the seven criteria that actually matter — including the elemental dose most labels obscure, the chelation yield 23 of 28 products fail, and the new 2025 sleep RCT no UK competitor cites.
Magnesium glycinate has become the most recommended supplement form for sleep, anxiety, and daily mineral support in the UK — and yet the market remains, charitably, a mess. Compound weights are inflated; elemental doses are buried; chelation yields go unverified; and the difference between a £8 bottle and a £45 bottle often comes down to specifications that no front label discloses. This is the audit we wish existed when we built our own.
Magnesium is one of the most studied minerals in nutritional science, and the body uses it in over 300 enzymatic reactions — from muscle contraction and nerve signalling to glucose metabolism, blood pressure regulation, and the synthesis of melatonin. The question for UK buyers is rarely whether to supplement, but which form to choose. The market is crowded with options that look interchangeable on a shelf but behave very differently in the body.
Magnesium oxide is the cheapest and most common form on UK supermarket shelves. It is also the worst absorbed — bioavailability studies place it at roughly 4% intestinal absorption (Walker et al., 2003), meaning the majority of the dose passes through the body without entering circulation. Magnesium oxide is what fills the £4 supermarket bottle. It is the reason so many UK adults take magnesium and report no effect.
Magnesium citrate is well-absorbed and inexpensive, but it has a meaningful osmotic effect on the gastrointestinal tract — at doses above 200–300mg elemental, it functions as a mild laxative. For some people that is welcome; for most adults supplementing for sleep, anxiety, or daily mineral support, it is the wrong tool. Our Magnesium Glycinate vs Citrate guide covers this distinction in full.
Magnesium glycinate — the form that is the subject of this article — is magnesium bonded to two molecules of the amino acid glycine. The bond is what makes this form different from the others, and it changes the supplement in three ways that matter for clinical effect: superior bioavailability, gentleness on the digestive tract, and the synergistic effect of glycine itself, which acts on NMDA receptors and inhibitory neurotransmitter pathways implicated in sleep and relaxation (Hausenblas et al., 2025). For the deeper comparison of magnesium glycinate against other chelated forms, our Magnesium Bisglycinate vs Glycinate and Magnesium Glycinate vs Oxide guides go deeper. For the full benefits profile of this specific form, see Magnesium Glycinate Benefits.
Most UK adults are estimated to fall short of the NHS reference intake through diet alone — a problem covered in detail in our Magnesium Deficiency Symptoms UK guide. The broader cluster of magnesium applications — from Magnesium and Sleep through Magnesium for Muscle Recovery and Magnesium and Vitamin D co-supplementation — is mapped across our broader magnesium guide library, all of which connects back to the foundational Magnesium Supplements Guide.
The supplement on the shelf is not the same as the supplement in the trial. Without standardisation and chelation verification, the label is a marketing artefact.
This is the single most important section in this entire guide. If you read nothing else, read this.
Magnesium glycinate is a chelated compound: a single magnesium ion bonded to two glycine molecules. By molecular weight, magnesium accounts for approximately 14% of the total compound mass. The remaining 86% is glycine — useful, but not magnesium. This means that when a UK label proudly displays "1,500mg of magnesium glycinate," the actual amount of elemental magnesium delivered to your bloodstream is closer to 210mg.
The NHS reference intake for elemental magnesium is 270mg per day for adult women and 300mg per day for adult men. This is the figure your body actually uses. Magnesium oxide, magnesium citrate, magnesium glycinate, magnesium malate — they are all just delivery vehicles. The elemental dose is what counts.
Most UK supplement labels quote compound weight on the front because it is the bigger, more impressive number. A label that reads "1,500mg magnesium glycinate" looks materially stronger than "210mg elemental magnesium" — even though they describe the same product. This is not necessarily dishonesty; the EU and UK supplement labelling regulations permit compound weight to be displayed prominently. But it does mean that comparing UK products by their front-label figure is comparing the wrong number.
For a deeper exploration of this calculation specifically as it applies to the magnesium glycinate form, our Elemental Magnesium and Magnesium Glycinate guide is the most thorough resource on this site.
An independent supplement laboratory (TopCertified, May 2026) tested 28 magnesium glycinate products against the chelation yield standard — the percentage of magnesium that is genuinely bonded to glycine in the final formulation, rather than existing as free magnesium ions or as oxide contamination. 23 of the 28 products failed the 10–14% chelation yield threshold that defines real chelated magnesium glycinate.
This is a significant finding for UK buyers. It means that the majority of products marketed as "magnesium glycinate" contain little or no actual chelated glycinate — instead, they contain cheaper magnesium forms (often oxide) with a small percentage of glycinate added so the label can carry the more premium name. Without chelation verification on the Certificate of Analysis, the front-of-pack claim is essentially unverifiable by the consumer.
This is why we built the 7-Point Audit framework — to give UK buyers a way to evaluate magnesium glycinate products against the criteria that actually determine clinical effect. Front-label compound weight is a vanity number. Elemental dose, chelation verification, third-party testing, and form purity are the substance.
A genuine magnesium glycinate product will state: the elemental magnesium dose explicitly (not just compound weight), chelation type confirmed (true chelated bisglycinate, not "glycinate complex"), third-party CoA available or batch-tested at GMP facility, and no magnesium oxide listed as a secondary ingredient (the cheap filler that lets brands claim "magnesium glycinate complex").
The framework below is the standard against which every UK magnesium glycinate product in this guide has been scored. Each criterion is weighted by clinical and practical relevance to the average UK buyer. The maximum score is 49. We apply the same audit to our own product without favouritism — Elysium Magnesium Glycinate scores 47/49, with the 2 deducted points reflecting items on our 2026 roadmap.
Each criterion reflects a specific dimension of magnesium glycinate quality that influences clinical effect, safety, or value-per-elemental-milligram.
What follows is the independent audit of eight UK magnesium glycinate products against the 7-Point framework above. Brands are listed in order of audit score, highest first. Pricing is current as of June 2026 and may fluctuate; per-serving figures are calculated from the latest publicly available product specifications. We have included our own product, scored against the same criteria, in the appropriate ranking position.
Elysium Magnesium Glycinate delivers 240mg of elemental magnesium per single-capsule serving — approximately 89% of the NHS reference intake for adult women in one capsule. The product uses true chelated bisglycinate, is UK GMP manufactured, contains no magnesium oxide filler, and discloses the elemental dose explicitly on the front label. Two points deducted: proactive public CoA publication (currently available on request; published per-batch CoA on the roadmap for Q3 2026) and the absence of independent third-party verification beyond UK GMP batch testing. View product.
Thorne's magnesium bisglycinate is one of the most clinically reputable products available to UK buyers, with NSF certification (a significant third-party verification above standard GMP). The powder format provides dose flexibility but is less convenient than capsules. Per-serving cost is approximately £0.67 — among the higher pricing in the category but justified by the verification standards. Loses points on value per elemental mg (premium pricing for slightly lower elemental dose than Elysium per serving).
Pure Encapsulations is the UK reference brand for clinician-grade supplementation. Strong on transparency, hypoallergenic formulation, and quality assurance. Elemental dose per capsule is lower than Elysium (120mg vs 240mg), meaning users targeting the NHS reference intake need 2+ capsules daily. Premium pricing reflects the brand positioning rather than uniquely superior chemistry. Loses points primarily on value per elemental milligram.
Vitabright is a credible UK Amazon brand that features in mainstream supplement roundups. Reasonable price, UK manufactured, and uses the glycinate form. The principal gaps in our audit: limited explicit elemental dose disclosure on the front label, no publicly published CoA, and the chelation yield is unverified — leaving the consumer dependent on the brand's claim rather than third-party verification.
Solgar uses the Albion chelated magnesium technology — a credible chelation process — and is widely stocked in UK pharmacies and Holland & Barrett. The elemental dose per tablet (100mg) is relatively low; UK adults targeting the NHS reference intake need 2–3 tablets daily, which raises the effective cost per elemental milligram. Solgar's chelated form is not necessarily bisglycinate specifically — it is a broader chelated category — which we've factored into the form score.
Wild Nutrition's Food-Grown range uses yeast-matrix delivery rather than chelated bisglycinate specifically — a different mechanism with its own bioavailability rationale but less directly comparable to the RCT evidence base for magnesium glycinate. For consumers prioritising food-matrix delivery and the broader brand philosophy, Wild Nutrition is credible; for consumers seeking the chelated glycinate form that the clinical trials used, a true bisglycinate product is more appropriate.
H&B's own-brand bisglycinate is the most widely accessible option for UK consumers, with high street availability and a clear front-label form claim. The label states 375mg of magnesium bisglycinate per capsule (delivering ~52mg elemental) — meaning users targeting the NHS reference intake need 5–6 capsules. Limited elemental dose disclosure, no publicly published CoA, and the H&B own-brand supply chain provides less transparency than independent specialist brands.
Nutravita is a high-volume UK Amazon brand offering large pack sizes at competitive prices. The principal gaps are limited elemental dose transparency, no publicly published Certificate of Analysis, and reliance on Amazon-driven supply chain rather than dedicated specialist manufacturing. For budget-conscious users supplementing on top of strong dietary magnesium intake, Nutravita is defensible; for buyers seeking the highest-quality chelated bisglycinate with full transparency, other options score higher.
The clinical evidence base for magnesium supplementation is decades old, but the evidence specifically for magnesium glycinate (bisglycinate) was, until 2025, thinner than the broader category suggested. That changed materially with the publication of Hausenblas et al. in Nature and Science of Sleep in late 2025 — the first nationwide, home-based, randomised, placebo-controlled trial of magnesium bisglycinate specifically for sleep outcomes. The shift in the evidence base is meaningful, and we cover it in detail below.
This was a nationwide, home-based, four-week, randomised, double-blind, placebo-controlled trial in 153 healthy adults reporting poor sleep quality. Participants received magnesium bisglycinate or a visually-matched placebo for 28 days. Sleep was measured using the Insomnia Severity Index (ISI) and additional validated questionnaires.
The headline finding: magnesium bisglycinate produced a statistically significant improvement in ISI scores compared to placebo, in both intention-to-treat and per-protocol analyses. The effect size was modest but real — and meaningful given the relatively short 4-week intervention period. Participants with the lowest baseline dietary magnesium intake appeared to benefit most, consistent with the broader literature suggesting that supplementation is most effective in those who are most depleted.
This trial is the highest-quality dedicated magnesium bisglycinate sleep RCT to date. It corrects a notable evidence gap. Zero UK supplement brands currently cite this study in their product or content marketing. Elysium is the first.
Two mechanisms appear to drive the sleep effect. First, magnesium itself modulates the GABAergic system — the primary inhibitory neurotransmitter system implicated in sleep onset, anxiety, and central nervous system arousal. Second, the glycine component is itself biologically active: glycine interacts with NMDA receptors and has been independently associated with improved sleep architecture and reduced core body temperature, both of which support sleep onset. The combination is more than additive — the magnesium-glycine complex may offer synergistic effects beyond either component alone (Hausenblas et al., 2025).
Magnesium is depleted by chronic cortisol exposure, and magnesium depletion in turn amplifies the stress response through NMDA receptor sensitisation and reduced GABAergic tone. The relationship is bidirectional and clinically meaningful. For the full mechanism, see our Magnesium and Cortisol deep guide. For the broader anxiety and stress applications, our Magnesium for Anxiety UK, Magnesium for Stress UK, and Magnesium Glycinate for Anxiety guides go deeper. The clinical foundation for HPA-axis dysregulation that magnesium supplementation addresses is covered in HPA Axis and Stress and the related Cortisol and Sleep reference.
The 2025 systematic review and meta-analysis by Khalili et al. (MDPI Antioxidants) confirmed magnesium's role in oxidative stress modulation, with glycinate and citrate identified as the forms most likely to deliver consistent serum magnesium uptake. For the anxiety-specific evidence, the Boyle et al. 2017 review pooled trials in subclinical anxiety populations and found significant effects for magnesium supplementation across forms.
The Hausenblas et al. (2025) trial deserves more thorough treatment than supplement brands typically afford it. The study design was rigorous: nationwide US recruitment, home-based supplementation (better external validity than clinic-based trials), 4-week intervention, validated sleep questionnaires, and both intention-to-treat and per-protocol analyses. The intervention was a standardised dose of magnesium bisglycinate; the comparator was a visually-matched placebo.
The 153-participant sample was the largest dedicated magnesium bisglycinate sleep trial to date. Inclusion criteria were healthy adults with self-reported poor sleep quality — closely matching the population most likely to be considering supplementation. The Insomnia Severity Index improvements were statistically significant; secondary measures of sleep efficiency and daytime function showed favourable trends.
The clinical takeaway: there is now Level 2 evidence (well-conducted RCT) for magnesium bisglycinate specifically for sleep outcomes in adults reporting poor sleep quality. This sits within a broader meta-analytic literature on magnesium for sleep that includes the older adults systematic review demonstrating a ~17-minute reduction in sleep onset latency (Consensus 2024, citing earlier RCT data). For dedicated guidance on sleep timing and dosing, see Magnesium Glycinate for Sleep and Best Magnesium for Sleep UK.
The relationship between magnesium status and anxiety is one of the more interesting findings in nutritional psychiatry research. Multiple observational studies have demonstrated inverse correlations between dietary magnesium intake and self-reported anxiety. The Boyle et al. (2017) systematic review of RCTs in subclinical anxiety populations found statistically significant reductions in anxiety scores across magnesium intervention trials, though heterogeneity in form, dose, and duration limited the strength of the recommendation.
Magnesium glycinate is the form most often recommended for anxiety supplementation specifically, for two reasons. First, the GABAergic mechanism is most likely to be relevant to anxiolytic effect at non-laxative doses (i.e., glycinate works at doses citrate cannot tolerate without causing GI distress). Second, the glycine component is itself implicated in inhibitory neurotransmission, contributing additively to the anxiolytic profile.
For the deeper magnesium-anxiety relationship, our dedicated Magnesium Glycinate for Anxiety guide is the most thorough resource. For broader anxiety strategy across the supplement category, see Best Supplements for Anxiety UK.
Magnesium dosing in the clinical literature is consistently expressed in elemental milligrams — and this is the figure to which UK consumers should anchor every purchasing decision. The NHS reference intake (RI) is the practical starting point.
| Goal | Elemental dose (mg/day) | Equivalent compound | Evidence | Notes |
|---|---|---|---|---|
| NHS reference intake (women) | 270mg | ~1,930mg glycinate | NHS guidance | Daily baseline; combine diet + supplementation |
| NHS reference intake (men) | 300mg | ~2,140mg glycinate | NHS guidance | Daily baseline; higher demand than women |
| Sleep support | 200–300mg | ~1,430–2,140mg glycinate | Hausenblas 2025; Cao 2024 | Taken 60–90 min before bed |
| Anxiety / stress | 200–400mg | ~1,430–2,860mg glycinate | Boyle 2017; Khalili 2025 | Often split AM and evening |
| UL (upper level from supplementation) | 400mg | ~2,860mg glycinate | EFSA upper level | Above this, GI side effects more likely |
For the dosing question specifically — "how much per day" — our How Much Magnesium Should I Take and Magnesium Glycinate Dosage guides are the dedicated references. For the specific question of whether 400mg is too much, see Is 400mg of Magnesium Glycinate Too Much. For the dosage question specifically as it relates to anxiety, our Magnesium Glycinate Dosage for Anxiety guide is more granular. The underlying Magnesium Glycinate Absorption reference covers the bioavailability question in detail.
For sleep-specific use: 60–90 minutes before bed aligns the peak plasma concentration with sleep onset, leveraging both the GABAergic effect and the glycine-driven core body temperature reduction. The Hausenblas 2025 trial used evening dosing. For the specific question of "best time" for sleep, see Best Time to Take Magnesium Glycinate for Sleep and the bedside dosing detail in Magnesium Glycinate Dosage for Sleep.
Magnesium glycinate is gentle on the GI tract and can be taken with or without food. Many users find that taking it on an empty stomach in the evening reduces the time-to-effect for sleep onset support. If you experience any GI discomfort, switch to with-meal dosing.
Unlike pharmaceutical interventions, magnesium glycinate works through gradual cellular repletion rather than acute pharmacological effect. The Hausenblas 2025 trial measured outcomes at 4 weeks; broader literature suggests 8 weeks for full repletion in deficient individuals. Here is what to expect.
Magnesium glycinate is among the most well-tolerated magnesium forms, but several contraindications warrant attention. Individuals with severe kidney impairment should not supplement magnesium without medical supervision — the kidneys are the primary route of magnesium excretion. Individuals with myasthenia gravis, certain cardiac conduction disorders, or on concurrent magnesium-containing medications (some antacids, some laxatives) should consult a GP before adding a magnesium supplement. For the full safety profile, see our Magnesium Glycinate Side Effects dedicated guide.
Mild GI effects (loose stools) occur at high doses — particularly above the EFSA upper level of 400mg elemental from supplementation. Below this level, glycinate is significantly gentler than citrate or oxide and is generally well-tolerated in healthy adults. Anyone with chronic kidney disease, severe renal impairment, or on dialysis should not supplement without medical guidance regardless of dose.
Magnesium has several documented or theoretical drug interactions. The most clinically relevant:
If you take prescription medication, consult your GP or pharmacist before starting magnesium supplementation. For the broader UK regulatory context on supplement-medication interactions, see our UK Supplement Regulations Guide.
In the United Kingdom, magnesium glycinate is classified as a food supplement under the Food Supplements (England) Regulations 2003 and equivalent devolved regulations. The form (bisglycinate) is permitted under retained EU Regulation 1170/2009 on substances that may be added to food supplements. This means UK products can use the form without additional novel food approval.
The Food Standards Agency permits authorised health claims under retained EU Regulation 432/2012. Magnesium is approved for claims relating to: normal psychological function, normal functioning of the nervous system, electrolyte balance, normal energy-yielding metabolism, normal muscle function, normal protein synthesis, maintenance of normal bones and teeth, and reduction of tiredness and fatigue. Crucially, claims about "sleep" and "anxiety" specifically are not on the authorised health claim list — meaning UK product labels cannot directly say "improves sleep" even where the clinical evidence supports the underlying mechanism.
This is why research literacy matters: reading the trial evidence directly is more informative than reading the label, which is constrained by the authorised claim list. For the full UK regulatory framework, our UK Supplement Regulations Guide and How to Read Supplement Labels UK guides are the dedicated resources.
The combination of magnesium glycinate with ashwagandha (specifically KSM-66®) is one of the most mechanistically coherent stacking decisions in the stress, sleep, and HPA axis category. The two interventions act through complementary, non-overlapping pathways.
Ashwagandha modulates the hypothalamic-pituitary-adrenal axis at the top of the stress cascade — reducing the hormonal signal that drives cortisol output. Magnesium glycinate addresses the downstream consequences of chronic cortisol elevation on the central nervous system: cortisol depletes intracellular magnesium, and magnesium deficiency amplifies the stress response. Restoring magnesium status while addressing the upstream cortisol driver is more clinically rational than either intervention alone.
For dedicated guidance on stacking these two specifically, see our Magnesium and Ashwagandha Together guide and our Ashwagandha and Cortisol UK 2026 deep clinical guide. For the broader cortisol-magnesium relationship, see Magnesium and Cortisol. For the foundational dosing decision underpinning the ashwagandha side of the stack, our Ashwagandha Dosage and Best Ashwagandha UK guides are the relevant references. For users adding a cognitive-performance dimension to the stack, Lion's Mane is often paired alongside — see Ashwagandha and Lion's Mane Together. The complete two-product approach is the foundation of our Stress & Focus Stack, and adaptogens generally are mapped in our Adaptogens UK reference. For the broader supplementation system, see the Complete Wellness System.
240mg elemental magnesium per single-capsule serving. True chelated bisglycinate, UK GMP manufactured, no proprietary blends. The dose the NHS reference intake actually requires.
View Magnesium Glycinate
Lion's Mane and Ashwagandha. Together, by design.
SHOP THE STRESS & FOCUS STACK
